Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2022

Apr 12, 2022

30371_dirs_2022-04-12_673380db-2342-4f1c-a526-88e67216104d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2022-04-08

Reporting Person: Flannelly Barry P (EVP & General Manager US)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-04-08 Common Stock M 20516 $68.62 Acquired 87808 Direct
2022-04-08 Common Stock S 20516 $83.01 Disposed 67292 Direct
2022-04-08 Common Stock M 21348 $72.27 Acquired 88640 Direct
2022-04-08 Common Stock S 21348 $84.00 Disposed 67292 Direct
2022-04-08 Common Stock S 881 $82.96 Disposed 66411 Direct
2022-04-08 Common Stock S 1248 $82.96 Disposed 65163 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-04-08 Non-Qualified Stock Option (right to buy) $68.62 M 20516 Disposed 2028-07-01 Common Stock (20516) Direct
2022-04-08 Non-Qualified Stock Option (right to buy) $72.27 M 21348 Disposed 2029-01-03 Common Stock (21348) Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.

F2: Includes an aggregate of 64,148 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

F3: Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.

F4: Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.